跳至主要内容
临床试验/NCT05940857
NCT05940857招募中不适用

US National OCS Liver Perfusion (OLP) Registry

TransMedics22 个研究点 分布在 1 个国家目标入组 100,000 人开始时间: 2021年10月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
TransMedics
入组人数
100,000
试验地点
22
主要终点
Survival

研究概览

简要总结

This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight.

TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Survival

时间窗: 5 years post-transplant

Recipients' patient and graft survival rates will be the primary clinical outcomes measures for all OCS Liver transplanted recipients compared to recipients receiving liver transplants using non-OCS preservation methods (cold static storage or other perfusion devices or a combination of both). This data will be obtained directly from UNOS/OPTN database.

次要结局

未报告次要终点

研究者

发起方
TransMedics
申办方类型
Industry
责任方
Sponsor

研究点 (22)

Loading locations...

相似试验